Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitin Chitranshi

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Aging and Disease|November 14, 2023
Molecular Mechanisms of Glaucoma Pathogenesis with Implications to Caveolin Adaptor Protein and Caveolin-Shp2 AxisMojdeh Abbasi, Vivek Gupta, Nitin Chitranshi, et al.
Journal of Visualized Experiments : Jove|August 15, 2015
Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve DemyelinationYuyi You, Vivek K Gupta, Nitin Chitranshi, et al.
Investigative Ophthalmology & Visual Science|March 22, 2019
Sex-Specific Effect of BDNF Val66Met Genotypes on the Progression of Open-Angle GlaucomaTing Shen, Vivek K Gupta, Alexander Klistorner, et al.
Current Pharmaceutical Design|February 14, 2025
Epigenetics Modulators as Therapeutics for Neurological DisordersMansi Gaba, Ashwani Sharma, Nitin Chitranshi, et al.
Frontiers in Cellular Neuroscience|April 12, 2018
Regulation of Brain-Derived Neurotrophic Factor and Growth Factor Signaling Pathways by Tyrosine Phosphatase Shp2 in the Retina: A Brief ReviewMojdeh Abbasi, Vivek Gupta, Nitin Chitranshi, et al.
Journal of Biomolecular Structure & Dynamics|December 31, 2021
Computational refinement identifies functional destructive single nucleotide polymorphisms associated with human retinoid X receptor geneSoumalya Sarkar, Vivek K Gupta, Samridhi Sharma, et al.
Progress in Neurobiology|March 17, 2023
Extracellular vesicles as reconfigurable therapeutics for eye diseases: Promises and hurdlesFaezeh Shekari, Morteza Abyadeh, Anna Meyfour, et al.
Neuroscience|August 22, 2024
RXR agonist, 9-cis-13,14-dihydroretinoic acid (9CDHRA), reduces damage and protects from demyelination in transsynaptic degeneration modelGabriella E Parrilla, Roshana Vander Wall, Nitin Chitranshi, et al.
Molecular Aspects of Medicine|October 19, 2023
Signalling pathways and cell death mechanisms in glaucoma: Insights into the molecular pathophysiologyDevaraj Basavarajappa, Caridad Galindo-Romero, Vivek Gupta, et al.
Neuroscience|September 27, 2017
PTPN11 induces endoplasmic stress and apoptosis in SH-SY5Y cellsNitin Chitranshi, Yogita Dheer, Veer Gupta, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Aging and Disease|November 14, 2023
Molecular Mechanisms of Glaucoma Pathogenesis with Implications to Caveolin Adaptor Protein and Caveolin-Shp2 AxisMojdeh Abbasi, Vivek Gupta, Nitin Chitranshi, et al.
Journal of Visualized Experiments : Jove|August 15, 2015
Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve DemyelinationYuyi You, Vivek K Gupta, Nitin Chitranshi, et al.
Investigative Ophthalmology & Visual Science|March 22, 2019
Sex-Specific Effect of BDNF Val66Met Genotypes on the Progression of Open-Angle GlaucomaTing Shen, Vivek K Gupta, Alexander Klistorner, et al.
Current Pharmaceutical Design|February 14, 2025
Epigenetics Modulators as Therapeutics for Neurological DisordersMansi Gaba, Ashwani Sharma, Nitin Chitranshi, et al.
Frontiers in Cellular Neuroscience|April 12, 2018
Regulation of Brain-Derived Neurotrophic Factor and Growth Factor Signaling Pathways by Tyrosine Phosphatase Shp2 in the Retina: A Brief ReviewMojdeh Abbasi, Vivek Gupta, Nitin Chitranshi, et al.
Journal of Biomolecular Structure & Dynamics|December 31, 2021
Computational refinement identifies functional destructive single nucleotide polymorphisms associated with human retinoid X receptor geneSoumalya Sarkar, Vivek K Gupta, Samridhi Sharma, et al.
Progress in Neurobiology|March 17, 2023
Extracellular vesicles as reconfigurable therapeutics for eye diseases: Promises and hurdlesFaezeh Shekari, Morteza Abyadeh, Anna Meyfour, et al.
Neuroscience|August 22, 2024
RXR agonist, 9-cis-13,14-dihydroretinoic acid (9CDHRA), reduces damage and protects from demyelination in transsynaptic degeneration modelGabriella E Parrilla, Roshana Vander Wall, Nitin Chitranshi, et al.
Molecular Aspects of Medicine|October 19, 2023
Signalling pathways and cell death mechanisms in glaucoma: Insights into the molecular pathophysiologyDevaraj Basavarajappa, Caridad Galindo-Romero, Vivek Gupta, et al.
Neuroscience|September 27, 2017
PTPN11 induces endoplasmic stress and apoptosis in SH-SY5Y cellsNitin Chitranshi, Yogita Dheer, Veer Gupta, et al.
Pageof 8